Recent News

• 03.11.2025 - BrainsWay Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights
• 03.04.2025 - BrainsWay to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
• 02.24.2025 - BrainsWay to Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025
• 12.12.2024 - BrainsWay Reports Positive Independent Pilot Data on Accelerated Deep TMS Treatment of Alcohol Use Disorder
• 11.20.2024 - BrainsWay Reports Promising Feasibility Data Showing Pain Reduction with Deep TMS Therapy
• 09.30.2024 - BrainsWay Announces US$20 Million Private Placement with Valor Equity Partners

Recent Filings

• 03.11.2025 - EX-99.1 EX-99.1
• 03.11.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 01.28.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 12.12.2024 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 12.12.2024 - EX-99.1 EX-99.1
• 11.20.2024 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 11.14.2024 - SC 13G/A Statement of Beneficial Ownership by Certain Investors
• 11.14.2024 - SC 13G/A Statement of Beneficial Ownership by Certain Investors
• 11.13.2024 - SC 13D General Statement of Acquisition of Beneficial Ownership
• 11.12.2024 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]